Sandbox Reserved 1066: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 48: Line 48:
''Mycobacterium tuberculosis'' ''(M.tb)'' is the causative agent involved in the disease '''tuberculosis'''. Tuberculosis is a growing global health concern that has been intensified due to the increase in HIV infections along with the increase in multi-drug resistance strains of ''(M. tb)'' <ref name="molecular studies">PMID: 20454815</ref>. Most of the drug resistance has evolved due to the intensive nature of the treatment for tuberculosis, which often goes incomplete thus resulting in drug resistant strains; therefore, the importance in identifying characteristics and residues to be exploited for new drug targets is pivotal <ref name="molecular studies"/>.
''Mycobacterium tuberculosis'' ''(M.tb)'' is the causative agent involved in the disease '''tuberculosis'''. Tuberculosis is a growing global health concern that has been intensified due to the increase in HIV infections along with the increase in multi-drug resistance strains of ''(M. tb)'' <ref name="molecular studies">PMID: 20454815</ref>. Most of the drug resistance has evolved due to the intensive nature of the treatment for tuberculosis, which often goes incomplete thus resulting in drug resistant strains; therefore, the importance in identifying characteristics and residues to be exploited for new drug targets is pivotal <ref name="molecular studies"/>.
   
   
The cell wall of ''(M. tb)'' is known to be composed and synthesized from a distinct variety of lipids, most notably mycolic aicds, which are known to play a crucial role in pathogenesis of ''(M. tb)'' <ref name="molecular studies"/>.
The cell wall of ''(M. tb)'' is known to be composed and synthesized from a distinct variety of lipids, most notably mycolic acids, which are known to play a crucial role in pathogenesis of ''(M. tb)'' <ref name="molecular studies"/>.


== Relevance of key mutational studies to the understanding and development of new inhibitors for FadD13 ==
== Relevance of key mutational studies to the understanding and development of new inhibitors for FadD13 ==

Revision as of 02:07, 9 April 2015

This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Mycobacterium tuberculosis very-long-chain fatty acyl-CoA synthetase

Very Long Chain Fatty Acyl CoA Synthetase (FadD13)

Drag the structure with the mouse to rotate


References



External Resources

Tuberculosis Wikipedia page

Mycobacterium tuberculosis Wikipedia page

Coenzyme A Wikipedia page

Acyl CoA Wikipedia Page

Mycolic Acid Wikipedia page